UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 Receptors

Not Applicable

Terminated

Conditions: Cervical Prostaglandin EP3 Receptors
Pregnancy

Interventions: Other: Non-treatment
Drug: Mifepristone

First Posted Date: 2010-10-20

Last Posted Date: 2010-10-20

Lead Sponsor: University of Southern California

Target Recruit Count: 18

Registration Number: NCT01224509

Locations: 🇺🇸
Women's and Children's Hospital, Reproductive Research Center, Los Angeles, California, United States

Endoscopic Breast Surgery in Treating Patients With Breast Cancer

Not Applicable

Terminated

Conditions: Male Breast Cancer
Recurrent Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIIC Breast Cancer
Stage IV Breast Cancer

Interventions: Procedure: endoscopic surgery
Procedure: quality-of-life assessment

First Posted Date: 2010-10-18

Last Posted Date: 2014-02-06

Lead Sponsor: University of Southern California

Target Recruit Count: 2

Registration Number: NCT01222377

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Not Applicable

Completed

Conditions: Ductal Breast Carcinoma in Situ
Lobular Breast Carcinoma in Situ
Stage IB Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
BRCA1 Mutation Carrier
BRCA2 Mutation Carrier
Stage IA Breast Cancer

Interventions: Other: placebo
Dietary Supplement: soy isoflavones
Other: questionnaire administration
Procedure: magnetic resonance imaging
Procedure: biopsy
Other: immunohistochemistry staining method
Other: laboratory biomarker analysis
Procedure: mammography

First Posted Date: 2010-10-13

Last Posted Date: 2023-11-18

Lead Sponsor: University of Southern California

Target Recruit Count: 110

Registration Number: NCT01219075

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Validation of the Stayhealthy BC1 Body Comp Analyzer

Not Applicable

Completed

Conditions: Body Composition

Interventions: Device: BC1

First Posted Date: 2010-09-27

Last Posted Date: 2022-01-13

Lead Sponsor: University of Southern California

Target Recruit Count: 362

Registration Number: NCT01209923

Locations: 🇺🇸
USC Clinical Exercise Research Center, Los Angeles, California, United States

Hydration Factor Study for the Stayhealthy BC3

Not Applicable

Completed

Conditions: Body Composition

Interventions: Device: D2O

First Posted Date: 2010-09-27

Last Posted Date: 2023-12-11

Lead Sponsor: University of Southern California

Target Recruit Count: 360

Registration Number: NCT01209936

Locations: 🇺🇸
USC Clinical Exercise Research Center, Los Angeles, California, United States

Ixabepilone and Pemetrexed/Solid Tumors

Phase 1

Withdrawn

Conditions: Advanced Solid Tumors

Interventions: Drug: Ixabepilone
Drug: Pemetrexed

First Posted Date: 2010-07-27

Last Posted Date: 2014-05-21

Lead Sponsor: University of Southern California

Registration Number: NCT01170871

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
Los Angeles County+University of Southern California Medical Center, Los Angeles, California, United States

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1

Completed

Conditions: Recurrent Breast Cancer
Recurrent Cervical Cancer
Recurrent Endometrial Carcinoma
Stage III Neuroendocrine Carcinoma of the Skin
Stage III Ovarian Epithelial Cancer
Stage IV Endometrial Carcinoma
Stage IV Neuroendocrine Carcinoma of the Skin
Stage IV Non-small Cell Lung Cancer
Stage IVA Cervical Cancer
Recurrent Gastrointestinal Carcinoid Tumor

Interventions: Drug: temsirolimus
Drug: vinorelbine ditartrate

First Posted Date: 2010-07-01

Last Posted Date: 2016-06-13

Lead Sponsor: University of Southern California

Target Recruit Count: 19

Registration Number: NCT01155258

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia

Phase 2

Terminated

Conditions: Hepatitis C Infection
Thrombocytopenia

Interventions: Biological: romiplostim
Drug: ribavirin
Other: placebo
Biological: PEG-interferon alfa-2a
Other: laboratory biomarker analysis

First Posted Date: 2010-06-30

Last Posted Date: 2017-04-11

Lead Sponsor: University of Southern California

Target Recruit Count: 27

Registration Number: NCT01153919

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Exercise Program for Early Breast Cancer Survivors

Not Applicable

Completed

Conditions: Stage IIIA Breast Cancer
Stage I Breast Cancer
Stage IIIC Breast Cancer
Stage II Breast Cancer
Stage IIIB Breast Cancer

Interventions: Other: questionnaire administration
Procedure: quality-of-life assessment
Procedure: management of therapy complications
Behavioral: exercise intervention

First Posted Date: 2010-06-09

Last Posted Date: 2019-06-18

Lead Sponsor: University of Southern California

Target Recruit Count: 106

Registration Number: NCT01140282

Locations: 🇺🇸
USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

Early Small Bowel Obstruction Following Laparotomy For Trauma

Completed

Conditions: Small Bowel Obstruction

First Posted Date: 2010-02-12

Last Posted Date: 2016-05-12

Lead Sponsor: University of Southern California

Target Recruit Count: 571

Registration Number: NCT01068340

Locations: 🇺🇸
Los Angeles County + University of Southern California Medical Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy